CRT 2023
Interventional Hypertension (Non-CME)
Eric A. Secemsky, MD, MSc
Director of Vascular Intervention
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
Disclosure(s): Abbott, Bayer, BD, Boston Scientific, Cook, CSI, Inari, Medtronic, Philips, Shockwave and VentureMed.: Advisor (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Consulting fees or other remuneration (Ongoing), Grant/Research Support (Ongoing), Other Research Support (Ongoing), Scientific Advisory Board (Ongoing)
Vasilios Papademetriou, MD, DSc
Director Interventional Hypertension and Vascular Medicine
Georgetown University/VAMC
Washington, District of Columbia, United States
No relationships to disclose
Michael Weber, MD
Professor of Medicine
SUNY Downstate Medical College
Palm Beach Gardens, Florida, United States
Disclosure(s): Ablative Solutions: Consultant/Advisory Board (Ongoing); Medtronic: Consultant/Advisory Board (Ongoing); ReCor: Consultant/Advisory Board (Ongoing)
Justin E. Davies, MD, PhD
Cardiologist
Imperial College London
London, England, United Kingdom
No relationships to disclose
Tim A. Fischell, MD, FACC
Director of Cardiovascular Research
Ascension Borgess Heart Institute
Kalamazoo, Michigan, United States
Disclosure(s): Ablative Solutions, Inc.: Employee (Ongoing), Intellectual Property/Patents (Ongoing), Owner/Co-Owner Founder/Co-Founder (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing), Patent Holder (Ongoing), Royalties (Ongoing), Salary (Ongoing); Angel Medical Systems, Inc.: Intellectual Property/Patents (Ongoing), Major Stockholder (not including mutual funds) (Ongoing), Royalties (Ongoing); Vantis Vascular, Inc.: Board Member (Ongoing), Employee (Ongoing), Intellectual Property/Patents (Ongoing), Patent Holder (Ongoing), Salary (Ongoing)
Rich R. Heuser, MD, MSCAI
Interventional Cardiologist
Heart and Vascular Center of Arizona
Phoenix, Arizona, United States
Disclosure(s): PQ Bypass: Owner/Co-Owner Founder/Co-Founder (Ongoing); Verve Medical, Inc.: Board Member/Officer/Trustee (Ongoing)
David E. Kandzari, MD, FACC, FSCAI
Director, Interventional Cardiology, Piedmont Heart Institute; Chief Scientific Officer, Piedmont Healthcare
Piedmont Heart Institute
Atlanta, Georgia, United States
Disclosure(s): Medtronic: Advisor (Ongoing), Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing), Consultant (Ongoing), Consulting Fees (e.g., advisory boards) (Ongoing), Contracted Research (Ongoing)
Felix Mahfoud, MD
Professor
Saarland University Hospital
Homburg/Saar, Saarland, Germany
No relationships to disclose
John P. Reilly, MD
Chief of Cardiology
Stony Brook Southampton Hospital
Stony Brook, New York, United States
No relationships to disclose
Andrew SP Sharp, MD
Consultant Cardiologist
University Hospital of Wales
Cardiff, United Kingdom
Disclosure(s): Boston Scientific: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Medtronic: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Penumbra: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Philips: Consulting Fees (e.g., advisory boards) (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Recor Medical: Consultant/Advisory Board (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)
Judith Veis, MD
Section Director, Nephrology
Medstar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure(s): No financial relationships to disclose
William S. Weintraub, MD
Cardiologist
MedStar Washington Hospital Center
Washington, District of Columbia, United States
Disclosure(s): No financial relationships to disclose